Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FE1MB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $68,563
Award facts
- Contract value 100% obligated
- $68,563.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $68,563.04 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300 mg prefilled pens on September 29, 2025, with a completion date of September 30, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to the company's headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates capability across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. The DLA Troop Support Medical IDC enables AmerisourceBergen to supply pharmaceutical products to various government healthcare customers including the Defense Health Agency and U.S. Coast Guard, positioning the company as a key provider within the military's medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DB25FE1MB?
SPE2DB25FE1MB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 29, 2025.
How much is contract SPE2DB25FE1MB worth?
The government has obligated $68,563 on SPE2DB25FE1MB.
Is contract SPE2DB25FE1MB an order under another contract?
Yes. SPE2DB25FE1MB is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FE1MB competed?
The extent of competition for SPE2DB25FE1MB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award